Stock Rich List
#10353 on the rich list of 14,644 insiders

Fady Ibraham Malik

EVP Research & Development at Cytokinetics; Director at Rocket Pharmaceuticals. Based in South San Francisco, California.

$8.0M
in disclosed stock, +$22K (+0.27%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
10353rd of 14,644
Companies held
2
Largest holding
CYTK, 98.6% of total
Latest SEC filing
Nov 17, 2026

What the $8.0M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Cytokinetics CYTK
Common Stock
Directly153,902$51.46$7.9M98.6%Form 4, Nov 17, 2026
Rocket Pharmaceuticals RCKT
Common Stock
Directly52,862$2.11$112K1.4%Form 4, Jun 18, 2026

Share counts are the amounts Fady Ibraham Malik reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 17, 2026SoldCYTK3,300$51.73$171KView
Nov 17, 2026SoldCYTK200$52.59$11KView
Nov 3, 2026SoldCYTK3,500$62.93$220KView
Oct 20, 2026SoldCYTK3,500$64.01$224KView
Oct 6, 2026SoldCYTK3,500$61.38$215KView
Sep 22, 2026SoldCYTK3,500$68.29$239KView
Sep 8, 2026SoldCYTK3,500$75.46$264KView
Aug 18, 2026SoldCYTK3,500$75.82$265KView
Jul 21, 2026SoldCYTK3,500$80.59$282KView
Jul 7, 2026SoldCYTK3,500$86.62$303KView
Jun 23, 2026SoldCYTK3,500$79.51$278KView
Jun 9, 2026SoldCYTK3,500$67.98$238KView
May 19, 2026SoldCYTK3,500$75.69$265KView
May 5, 2026SoldCYTK3,500$77.37$271KView
Apr 21, 2026SoldCYTK3,500$65.69$230KView
Apr 7, 2026SoldCYTK1,000$64.75$65KView
Apr 7, 2026SoldCYTK3,500$65.21$228KView
Mar 17, 2026SoldCYTK4,397$62.15$273KView
Mar 17, 2026SoldCYTK7,636$62.15$475KView
Mar 9, 2026SoldCYTK2,907$60.72$177KView
Dec 16, 2025SoldCYTK2,200$61.24$135KView
Dec 2, 2025SoldCYTK2,200$63.89$141KView
Nov 18, 2025SoldCYTK2,200$66.45$146KView
Nov 4, 2025SoldCYTK2,295$59.55$137KView
Oct 21, 2025SoldCYTK2,105$58.22$123KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
10350Michael Brian Bell
Chief Financial Officer, Guardant Health. Palo Alto, CA
$8.0M+$25K (+0.31%)
10351Benjamin Polk
Insider, Monster Beverage. Corona, CA
$8.0M−$177K (−2.16%)
10352Adrian Joseph Daws
CEO, Hamilton Re, Hamilton Insurance Group
$8.0M−$113K (−1.38%)
10353Fady Ibraham Malik
EVP Research & Development, Cytokinetics. South San Francisco, CA
$8.0M+$22K (+0.27%)
10354Deborah L. Dyson
Corp. VP, Automatic Data Processing. Roseland, NJ
$8.0M−$117K (−1.43%)
10355Aaron Karczmer
EVP, Chief Enterprise Services, PayPal Holdings. San Jose, CA
$8.0M−$217K (−2.63%)
10356James A. Faulconbridge
Director, Hawkins. Roseville, MN
$8.0M−$112K (−1.38%)

Other Cytokinetics insiders

All CYTK insiders

Questions

How much stock does Fady Ibraham Malik own?

Fady Ibraham Malik holds $8,031,336 in listed stock based on SEC filings and current prices, mostly Cytokinetics (CYTK). That ranks 10353rd on the Stock Rich List.

Is this Fady Ibraham Malik's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Fady Ibraham Malik last buy or sell stock?

The most recent open-market trade on file is a sale of 3,300 CYTK shares on Nov 17, 2026 at $51.73.